Watson recalls one Propafenone HCL lot

Watson Pharmaceuticals is voluntarily recalling one lot of Propafenone HCL after it discovered that the drug, which is used to irregular heartbeats, may contain more of the active ingredient than it should. The lot in question was shipped to customers between October 15 and November 26, 2008. Report

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.